IMODIUM Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Imodium, and what generic alternatives are available?
Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs.
The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imodium
A generic version of IMODIUM was approved as loperamide hydrochloride; simethicone by PERRIGO on August 30th, 2002.
Summary for IMODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Clinical Trials: | 24 |
Patent Applications: | 4,914 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in IMODIUM? | IMODIUM excipients list |
DailyMed Link: | IMODIUM at DailyMed |

Recent Clinical Trials for IMODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Naia Pharmaceuticals | Phase 1/Phase 2 |
9 Meters Biopharma, Inc. | Phase 1/Phase 2 |
McNeil AB | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for IMODIUM
US Patents and Regulatory Information for IMODIUM
Expired US Patents for IMODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
J And J Consumer Inc | IMODIUM | loperamide hydrochloride | CAPSULE;ORAL | 017694-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
Janssen Pharms | IMODIUM | loperamide hydrochloride | SOLUTION;ORAL | 019037-001 | Jul 31, 1984 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for IMODIUM
See the table below for patents covering IMODIUM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 2167193 | See Plans and Pricing | |
Hong Kong | 78076 | 2,2-DIARYL-4-(4-ARYL-4-HYDROXY-PIPERIDINO)-BUTYRAMIDES | See Plans and Pricing |
Germany | 2126559 | See Plans and Pricing | |
Japan | S5936991 | See Plans and Pricing | |
Hungary | 166420 | See Plans and Pricing | |
Austria | 312606 | See Plans and Pricing | |
U.S.S.R. | 845776 | METHOD OF PREPARING 2,2-DIARYL-4-(4'-OXYPIPERIDINO)-BUTYLAMIDES OR THEIR SALTS | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for IMODIUM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0428296 | SPC/GB98/013 | United Kingdom | See Plans and Pricing | PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |